(E)-4-(2-Nitrovinyl)pyridine, 95%, 250mg

(4-(((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)methyl)phenyl)boronic acid, 95.0%, 250mg

(R)-2-Chloro-7-ethyl-8-isopropyl-7,8-dihydropteridin-6(5H)-one, 95.0%, 5g

N,N'-Dimethylethylenediamine, 97.0%, 25g

Methyl 4-(Cyanomethyl)benzoate>95.0%(GC)25g

Vaseline, Ph.Eur., 10 kg, plastic packaging.

Periodic acid, min. 99%, for synthesis, 500 g, glass packaging

Potassium hexafluorophosphate(V) 100 g

(S)-1-(2,4-Difluorophenyl)ethanamine, 95.0%, 1g

Methyl 3-fluoro-2-methoxybenzoate, 250mg

5,7,12,14-Pentacenetetrone>95.0%(HPLC)25g

Methyl 5-bromoquinoline-8-carboxylate, 95.0%, 10g

Ethyl 1-methyl-4-oxocyclohexanecarboxylate, 95.0%, 250mg